Journal of Pediatric Urology
Volume 6, Issue 4 , Pages 338-345 , August 2010

Non-neurogenic elimination disorders in children

  • Marc-David Leclair

      Affiliations

    • Paediatric Surgery and Urology Department, Hopital Mère-Enfant, CHU de NANTES, 44 093 Nantes Cedex, France
    • Corresponding Author InformationCorresponding author. Tel.: +33 240 08 35 85; fax: +33 240 08 35 46.
    • ,
  • Yves Héloury

      Affiliations

    • Paediatric Urology Department. Monash Medical Centre, Melbourne, Victoria, Australia

Received 22 October 2009 ,Accepted 11 January 2010.

References 

  1. Yeung CK. Pathophysiology of bladder dysfunction. In:  Gearhart JP,  Rink RC,  Mouriquand PDE editor. Pediatric urology. Philadelphia: WB Saunders; 2001;p. 453–469
  2. Franco I. Overactive bladder in children. Part 1: pathophysiology. J Urol. 2007;178(3 Pt 1):761–768discussion 8
  3. van Gool JD, de Jonge GA. Urge syndrome and urge incontinence. Arch Dis Child. 1989;64:1629–1634
  4. Homsy YL, Nsouli I, Hamburger B, Laberge I, Schick E. Effects of oxybutynin on vesicoureteral reflux in children. J Urol. 1985;134:1168–1171
  5. Koff SA. Relationship between dysfunctional voiding and reflux. J Urol. 1992;148(5 Pt 2):1703–1705
  6. Koff SA, Lapides J, Piazza DH. Association of urinary tract infection and reflux with uninhibited bladder contractions and voluntary sphincteric obstruction. J Urol. 1979;122:373–376
  7. Koff SA, Murtagh D. The uninhibited bladder in children: effect of treatment on vesicoureteral reflux resolution. Contrib Nephrol. 1984;39:211–220
  8. Koff SA, Murtagh DS. The uninhibited bladder in children: effect of treatment on recurrence of urinary infection and on vesicoureteral reflux resolution. J Urol. 1983;130:1138–1141
  9. Clayden G, Wright A. Constipation and incontinence in childhood: two sides of the same coin?. Arch Dis Child. 2007;92:472–474
  10. Halachmi S, Farhat WA. The impact of constipation on the urinary tract system. Int J Adolesc Med Health. 2008;20:17–22
  11. Franco I. Overactive bladder in children. Part 2: management. J Urol. 2007;178(3 Pt 1):769–774discussion 74
  12. Arya LA, Myers DL, Jackson ND. Dietary caffeine intake and the risk for detrusor instability: a case-control study. Obstet Gynecol. 2000;96:85–89
  13. Sureshkumar P, Bower W, Craig JC, Knight JF. Treatment of daytime urinary incontinence in children: a systematic review of randomized controlled trials. J Urol. 2003;170:196–200discussion 200
  14. Marschall-Kehrel D, Feustel C, Persson de Geeter C, Stehr M, Radmayr C, Sillén U, et al. Treatment with propiverine in children suffering from nonneurogenic overactive bladder and urinary incontinence: results of a randomized placebo-controlled phase 3 clinical trial. Eur Urol. 2009;182:2022–2026
  15. Youdim K, Kogan BA. Preliminary study of the safety and efficacy of extended-release oxybutynin in children. Urology. 2002;59:428–432
  16. Reinberg Y, Crocker J, Wolpert J, Vandersteen D. Therapeutic efficacy of extended release oxybutynin chloride, and immediate release and long acting tolterodine tartratein children with diurnal urinary incontinence. J Urol. 2003;169:317–319
  17. Hoebeke P, De Caestecker K, Vande Walle J, Dehoorne J, Raes A, Verleyen P, et al. The effect of botulinum-A toxin in incontinent children with therapy resistant overactive detrusor. J Urol. 2006;176:328–330discussion 30–1
  18. Chandra M, Saharia R, Shi Q, Hill V. Giggle incontinence in children: a manifestation of detrusor instability. J Urol. 2002;168:2184–2187discussion 7
  19. Wefer B, Seif C, van der Horst C, Junemann KP, Braun PM. [Botulinum toxin A injection for treatment-refractory giggle incontinence], Urologe A. 2007;46:773–775
  20. Sher PK, Reinberg Y. Successful treatment of giggle incontinence with methylphenidate. J Urol. 1996;156(2 Pt 2):656–658
  21. Berry AK, Zderic S, Carr M. Methylphenidate for giggle incontinence. J Urol. 2009 Aug 18;
  22. Rubenstein AH. Obesity: a modern epidemic. Trans Am Clin Climatol Assoc. 2005;116:103–111
  23. Nixon GM, Glazner JA, Martin JM, Sawyer SM. Urinary incontinence in female adolescents with cystic fibrosis. Pediatrics. 2002;110:e22
  24. Asnes RS, Mones RL. Extraordinary urinary frequency. Pediatrics. 1991;87:953
  25. Brock JW. The frequency and frequency dysuria syndromes of childhood: hypercalciuria as a possible etiology. Urology. 1994;44:411–412
  26. Parekh DJ, Pope JI, Adams MC, Brock JW. The role of hypercalciuria in a subgroup of dysfunctional voiding syndromes of childhood. J Urol. 2000;164(3 Pt 2):1008–1010
  27. Bergmann M, Corigliano T, Ataia I, Renella R, Simonetti GD, Bianchetti MG, et al. Childhood extraordinary daytime urinary frequency – a case series and a systematic literature review. Pediatr Nephrol. 2009;24:789–795
  28. Koff SA, Wagner TT, Jayanthi VR. The relationship among dysfunctional elimination syndromes, primary vesicoureteral reflux and urinary tract infections in children. J Urol. 1998;160(3 Pt 2):1019–1022
  29. Chen JJ, Mao W, Homayoon K, Steinhardt GF. A multivariate analysis of dysfunctional elimination syndrome, and its relationships with gender, urinary tract infection and vesicoureteral reflux in children. J Urol. 2004;171:1907–1910
  30. Van Gool J, Tanagho EA. External sphincter activity and recurrent urinary tract infection in girls. Urology. 1977;10:348–353
  31. Feldman AS, Bauer SB. Diagnosis and management of dysfunctional voiding. Curr Opin Pediatr. 2006;18:139–147
  32. Perez LM, Rushton HG. A pragmatic approach to the evaluation and management of non-neuropathic daytime voiding disorders. In:  Gearhart JP,  Rink RC,  Mouriquand PDE editor. Pediatric urology. Philadelphia: WB Saunders; 2001;p. 470–495
  33. Merlini E, Sangiorgio L, Seymandi P. The lazy bladder syndrome: a possible urodynamic evolution in patients with idiopathic detrusor and pelvic floor overactivity. Pediatr Med Chir. 2004;26:187–190
  34. Nijman RJ. Role of antimuscarinics in the treatment of nonneurogenic daytime urinary incontinence in children. Urology. 2004;63(Suppl. 1):45–50
  35. Bauer SB, Retik AB, Colodny AH, Hallett M, Khoshbin S, Dyro FM. The unstable bladder in childhood. Urol Clin North Am. 1980;7:321–336
  36. Ellsworth PI, Merguerian PA, Copening ME. Sexual abuse: another causative factor in dysfunctional voiding. J Urol. 1995;153(3 Pt 1):773–776
  37. Yeung CK, Godley ML, Dhillon HK, Duffy PG, Ransley PG. Urodynamic patterns in infants with normal lower urinary tracts or primary vesico-ureteric reflux. Br J Urol. 1998;81:461–467
  38. Yeung CK, Godley ML, Duffy PG, Ransley PG. Natural filling cystometry in infants and children. Br J Urol. 1995;75:531–537
  39. Yeung CK. The normal infant bladder. Scand J Urol Nephrol Suppl. 1995;173:19–23
  40. Bachelard M, Sillen U, Hansson S, Hermansson G, Jodal U, Jacobsson B. Urodynamic pattern in asymptomatic infants: siblings of children with vesicoureteral reflux. J Urol. 1999;162:1733–1737discussion 7–8
  41. Godley ML, Desai D, Yeung CK, Dhillon HK, Duffy PG, Ransley PG. The relationship between early renal status, and the resolution of vesico-ureteric reflux and bladder function at 16 months. BJU Int. 2001;87:457–462
  42. Sjostrom S, Sillen U, Bachelard M, Hansson S, Stokland E. Spontaneous resolution of high grade infantile vesicoureteral reflux. J Urol. 2004;172:694–698discussion 9
  43. Sillen U. Bladder dysfunction and vesicoureteral reflux. Adv Urol. 2008;815472
  44. van Gool JD, Hjalmas K, Tamminen-Mobius T, Olbing H. Historical clues to the complex of dysfunctional voiding, urinary tract infection and vesicoureteral reflux. The International Reflux study in children. J Urol. 1992;148(5 Pt 2):1699–1702
  45. Loening-Baucke V. Prevalence rates for constipation and faecal and urinary incontinence. Arch Dis Child. 2007;92:486–489
  46. Halachmi S, Farhat WA. Interactions of constipation, dysfunctional elimination syndrome, and vesicoureteral reflux. Adv Urol. 2008;828275
  47. Beer E. Chronic retention of urine in children. JAMA. 1915;65
  48. Hinman F. Nonneurogenic neurogenic bladder (the Hinman syndrome) – 15 years later. J Urol. 1986;136:769–777
  49. Allen TD. The non-neurogenic neurogenic bladder. J Urol. 1977;117:232–238
  50. Ochoa B. The urofacial (Ochoa) syndrome revisited. J Urol. 1992;148(2 Pt 2):580–583
  51. Ochoa B, Gorlin RJ. Urofacial (ochoa) syndrome. Am J Med Genet. 1987;27:661–667
  52. Wang CY, Davoodi-Semiromi A, Shi JD, Yang P, Huang YQ, Agundez JA, et al. High resolution mapping and mutation analyses of candidate genes in the urofacial syndrome (UFS) critical region. Am J Med Genet A. 2003;119A:9–14
  53. Jayanthi VR, Khoury AE, McLorie GA, Agarwal SK. The nonneurogenic neurogenic bladder of early infancy. J Urol. 1997;158:1281–1285
  54. Cheikhelard A, Chaouadi D, Teklali Y, Mouriquand PDE. Non obstructive congenital bladder and intestinal dysfunction (NOCOBLIND). J Pediatr Urol. 2006;2:1
  55. Vidal I, Heloury Y, Ravasse P, Lenormand L, Leclair MD. Severe bladder dysfunction revealed prenatally or during infancy. J Pediatr Urol. 2009;5:3–7
  56. Kari JA. Neuropathic bladder as a cause of chronic renal failure in children in developing countries. Pediatr Nephrol. 2006;21:517–520
  57. Garignon C, Mure PY, Paparel P, Chiche D, Mouriquand P. [Severe bladder dysfunction in the child abuse victim. Hinman syndrome]. Presse Med. 2001;30(39–40 Pt 1):1918–1923
  58. Handel LN, Barqawi A, Checa G, Furness PD, Koyle MA. Males with Down's syndrome and nonneurogenic neurogenic bladder. J Urol. 2003;169:646–649
  59. Kai N, Seki N, Hirata A, Nakamuta S, Naito S. A female case with Down syndrome and non-neurogenic neurogenic bladder. Int J Urol. 2007;14:867–868
  60. De Paepe H, Renson C, Hoebeke P, Raes A, Van Laecke E, Vande Walle J. The role of pelvic-floor therapy in the treatment of lower urinary tract dysfunctions in children. Scand J Urol Nephrol. 2002;36:260–267
  61. Combs AJ, Glassberg AD, Gerdes D, Horowitz M. Biofeedback therapy for children with dysfunctional voiding. Urology. 1998;52:312–315
  62. Lopez-Pereira P, Miguelez C, Caffarati J, Estornell F, Anguera A. Trospium cholride for the treatment of detrusor inctability in children. J Urol. 2003;170:1978–1981
  63. Cain MP, Wu SD, Austin PF, Herndon CD, Rink RC. Alpha-blocker therapy for children with dysfunctional voiding and urinary retention. J Urol. 2003;170:1514–1515
  64. DasGupta R, Murphy FL. Botulinum toxin in paediatric urology: a systematic literature review. Pediatr Surg Int. 2009;25:19–23
  65. Schurch B, Stohrer M, Kramer G, Schmid DM, Gaul C, Hauri D, et al. Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. J Urol. 2000;164:692–697
  66. Reitz A, Stohrer M, Kramer G, Del Popolo G, Chartier Kastler E, Panek J, et al. European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity. Eur Urol. 2004;45:510–515
  67. Schurch B, de Seze M, Denys P, Chartier Kastler E, Haab F, Everaert K, et al. Botulinum toxin type A is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo-controlled 6-month study. J Urol. 2005;174:196–200
  68. Sahai A, Khan MS, Dasgupta P. Efficacy of botulinum toxin-A for treating detrusor overactivity: results from a single center, randomized, double-blind, placebo-controlled trial. J Urol. 2007;177:2231–2236
  69. Phelan MW, Franks M, Somogyi GT, Yokoyama T, Fraser MO, Lavelle JP, et al. Botulinum toxin urethral sphincter injection to restore bladder emptying in men and women with voiding dysfunction. J Urol. 2001;165:1107–1110
  70. Radojicic ZI, Perovic S, Milic NM. Is it reasonable to treat refractory voiding dysfunction in children with botulinum-A toxin?. J Urol. 2006;176:332–336
  71. Guys JM, Haddad M, Planche D, Torre M, Louis-Borrione C, Breaud J. Sacral neuromodulation for neurogenic bladder dysfunction in children. J Urol. 2004;172:1673–1676
  72. Hoebeke P, Van Laecke E, Everaert K, Renson C, De Paepe H, Raes A, et al. Transcutaneous neuromodulation for the urge syndrome in children: a pilot study. J Urol. 2001;166:2416–2419
  73. Roth TJ, Vandersteen DR, Hollatz P, Inman BA, Reinberg YE. Sacral neuromodulation for the dysfunctional elimination syndrome: a single centre experience with 20 children. J Urol. 2008;180:306–311
  74. Combs AJ. Re: sacral neuromodulation for the dysfunctional elimination syndrome: a single centre experience with 20 children. J Urol. 2008;180:311

PII: S1477-5131(10)00009-4

doi: 10.1016/j.jpurol.2010.01.006

Journal of Pediatric Urology
Volume 6, Issue 4 , Pages 338-345 , August 2010

Article Tools